ERVW-1 and hepatocellular carcinoma: Since accumulation evidence showed that Syncytin-1 could regulate inflammatory abnormalities [5, 34], it is speculated that Syncytin-1 might aberrantly regulate the inflammation-activated pathway in HCC.